Tuesday, 23 April 2013

Fighting the 'dumb jock' stereotype

Fighting the 'dumb jock' stereotype [ Back to EurekAlert! ] Public release date: 22-Apr-2013
[ | E-mail | Share Share ]

Contact: Andy McGlashen
andy.mcglashen@cabs.msu.edu
517-355-5158
Michigan State University

EAST LANSING, Mich. College coaches who emphasize their players' academic abilities may be the best defense against the effects of "dumb jock" stereotypes, a Michigan State University study suggests.

Researchers found that student-athletes were significantly more likely to be confident in the classroom if they believed their coaches expected high academic performance, not just good enough grades to be eligible for sports.

"Coaches spend a lot of time with their players, and they can play such an important role to build academic confidence in student-athletes," said lead author Deborah Feltz, University Distinguished Professor of kinesiology at MSU.

Published in the Journal of College Student Development, the study focused on the concept of "stereotype threat." The theory holds that stereotypes are self-fulfilling prophecies: They create anxiety in the stereotyped group, causing them to behave in the expected way.

Feltz and her graduate students wanted to see what factors influence student-athletes' susceptibility to the "dumb jock" stereotype.

"It's well-documented in the literature that many student-athletes hear prejudicial remarks from professors who say things like, 'This test is easy enough that even an athlete could pass it,'" Feltz said. "They're kind of the last group of students who can be openly discriminated against."

The researchers surveyed more than 300 student-athletes representing men's and women's teams from small and large universities and a range of sports, from basketball and football to cross-country and rowing.

They found the more strongly student-athletes identified themselves as athletes, the less confident they were with their academic skills, and the more keenly they felt that others expected them to do poorly in school. Players in high-profile sports were more likely to feel they were weak students.

Feltz said the data suggest that coaches who put a premium on education may be in the best position to boost their players' confidence in the classroom, but professors, academic advisers and classmates also have a part to play.

"They don't have to do much," she said. "It may be enough to just remind players they are college students, which is a big deal, you know? A lot of these students are the first in their family to go to college."

###

Michigan State University has been working to advance the common good in uncommon ways for more than 150 years. One of the top research universities in the world, MSU focuses its vast resources on creating solutions to some of the world's most pressing challenges, while providing life-changing opportunities to a diverse and inclusive academic community through more than 200 programs of study in 17 degree-granting colleges.


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Fighting the 'dumb jock' stereotype [ Back to EurekAlert! ] Public release date: 22-Apr-2013
[ | E-mail | Share Share ]

Contact: Andy McGlashen
andy.mcglashen@cabs.msu.edu
517-355-5158
Michigan State University

EAST LANSING, Mich. College coaches who emphasize their players' academic abilities may be the best defense against the effects of "dumb jock" stereotypes, a Michigan State University study suggests.

Researchers found that student-athletes were significantly more likely to be confident in the classroom if they believed their coaches expected high academic performance, not just good enough grades to be eligible for sports.

"Coaches spend a lot of time with their players, and they can play such an important role to build academic confidence in student-athletes," said lead author Deborah Feltz, University Distinguished Professor of kinesiology at MSU.

Published in the Journal of College Student Development, the study focused on the concept of "stereotype threat." The theory holds that stereotypes are self-fulfilling prophecies: They create anxiety in the stereotyped group, causing them to behave in the expected way.

Feltz and her graduate students wanted to see what factors influence student-athletes' susceptibility to the "dumb jock" stereotype.

"It's well-documented in the literature that many student-athletes hear prejudicial remarks from professors who say things like, 'This test is easy enough that even an athlete could pass it,'" Feltz said. "They're kind of the last group of students who can be openly discriminated against."

The researchers surveyed more than 300 student-athletes representing men's and women's teams from small and large universities and a range of sports, from basketball and football to cross-country and rowing.

They found the more strongly student-athletes identified themselves as athletes, the less confident they were with their academic skills, and the more keenly they felt that others expected them to do poorly in school. Players in high-profile sports were more likely to feel they were weak students.

Feltz said the data suggest that coaches who put a premium on education may be in the best position to boost their players' confidence in the classroom, but professors, academic advisers and classmates also have a part to play.

"They don't have to do much," she said. "It may be enough to just remind players they are college students, which is a big deal, you know? A lot of these students are the first in their family to go to college."

###

Michigan State University has been working to advance the common good in uncommon ways for more than 150 years. One of the top research universities in the world, MSU focuses its vast resources on creating solutions to some of the world's most pressing challenges, while providing life-changing opportunities to a diverse and inclusive academic community through more than 200 programs of study in 17 degree-granting colleges.


[ Back to EurekAlert! ] [ | E-mail | Share Share ]

?


AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.


Source: http://www.eurekalert.org/pub_releases/2013-04/msu-ft042213.php

49ers news saint louis university night at the museum pope shenouda bolton muamba crystal cathedral sxsw

Monday, 22 April 2013

Xbox SmartGlass now available on Amazon's Kindle Fire tablets

Xbox SmartGlass now available on Amazon's Kindle Fire tablets

Amazon's just updated its Appstore today with a much welcome offering for avid gamers: Xbox SmartGlass. Microsoft's app-based second screen solution has been available on iOS and Android since late last fall, but despite sharing a kernel with Google's OS, hadn't been made dispensable to Kindle Fire / Fire HD owners until now. The app's been configured to scale natively on Amazon's refreshed tablet line, letting users navigate their Xbox 360 remotely, push and pull streaming content, as well as access achievements, messaging and Xbox Music. So if it's the living room of the future you're after, you might want to hit up the source and make that free download your own.

Filed under: , , , ,

Comments

Source: Amazon

Source: http://www.engadget.com/2013/04/22/xbox-smartglass-now-available-on-amazons-kindle-fire-tablets/?utm_medium=feed&utm_source=Feed_Classic&utm_campaign=Engadget

the time machine michelin tires michelin tires rett syndrome where the wild things are birdsong teresa giudice

Tuesday, 16 April 2013

Boston tragedy could delay immigration bill

Apr 15 (Reuters) - Leading money winners on the 2013 PGATour on Monday (U.S. unless stated): 1. Tiger Woods $4,139,600 2. Brandt Snedeker $3,137,920 3. Matt Kuchar $2,442,389 4. Adam Scott (Australia) $2,100,469 5. Steve Stricker $1,935,340 6. Phil Mickelson $1,764,680 7. Dustin Johnson $1,748,907 8. Jason Day $1,659,565 9. Hunter Mahan $1,553,965 10. Keegan Bradley $1,430,347 11. Charles Howell III $1,393,806 12. John Merrick $1,375,757 13. Russell Henley $1,331,434 14. Michael Thompson $1,310,709 15. Kevin Streelman $1,310,343 16. Bill Haas $1,271,553 17. Billy Horschel $1,254,224 18. ...

Source: http://news.yahoo.com/boston-tragedy-could-delay-immigration-bill-231759953--politics.html

patriots vs giants super bowl superbowl halftime show jason wu for target underwood buffalo wings superbowl kick off time 2012 new york giants

Monday, 1 April 2013

Facebook mystery Android news may be a home screen launcher: report?

Facebook's mysterious invite for its Thursday announcement has a clue in its wording ? "Come see our new home on Android" ? and it may be that the "home" refers to a new Facebook Home app that is a customized launcher for the social network.

The Android Police ? which assures this is not an April Fools' joke ? says it obtained a system dump of the ROM (read-only memory) from an HTC phone, believed to be the release unit for what Facebook is unveiling Thursday.

"According to this rom, the Facebook Phone looks to be a mostly stock, mid-range (HTC) Sense 4.5 phone that was attacked by a mutant Facebook app," writes Ron Amadeo on The Android Police. "Everything seems to be focused on the Facebook app ? they haven't made their own Android Skin, or anything like that. Sadly, we can't get too many more details, because just about everything requires that you have special access to Facebook."

The Android Police said among the set of permissions are those that allow Facebook to "read the settings for the stock Android launcher, the HTC launcher, and the (Samsung) Touchwiz Launcher. Having permissions for Touchwiz on an HTC phone is a dead giveaway that Facebook plans on releasing Facebook Home not just on this phone, but as a standalone app in the (Google) Play Store," for other Android users.

So while it's not a new operating system, it could be an uber-app that you spend most of your mobile life inside. The key will be if this so-called launcher encompasses Facebook apps of its own, particularly profitable games of the "FarmVille" and "Words With Friends" variety.

If it did, however, Google would probably view it as a break from Google-branded Android, and could block Facebook's new app from the Play Store ? or block Google apps such as Maps from shipping on devices that come with the Facebook launcher. All the more reason to watch Thursday's announcement with some attention to details.

We've asked Facebook to comment and will update this post if we hear back.

Check out Technology, GadgetBox, DigitalLife and InGame on Facebook, and on Twitter, follow Suzanne Choney.

Source: http://feeds.nbcnews.com/c/35002/f/653377/s/2a37b0d8/l/0L0Snbcnews0N0Ctechnology0Ctechnolog0Cfacebook0Emystery0Eandroid0Enews0Emay0Ebe0Ehome0Escreen0Elauncher0Ereport0E1C9157765/story01.htm

anna paquin warren buffett 2012 nfl schedule dishonored april 18 delonte west vanessa williams

India's top court to deliver Novartis judgment

FILE ? In this Jan. 29, 2007 file photo, Indian police officers block demonstrators protesting against Swiss drugmaker Novartis AG's case against the Indian government on drug patents in New Delhi, India. India's Supreme Court is to rule Monday, April 1, 2013, whether to deny a patent to Novartis AG for its cancer treatment in a landmark case that would allow Indian companies to continue producing cheaper versions of many lifesaving medicines. (AP Photo/Saurabh Das, File)

FILE ? In this Jan. 29, 2007 file photo, Indian police officers block demonstrators protesting against Swiss drugmaker Novartis AG's case against the Indian government on drug patents in New Delhi, India. India's Supreme Court is to rule Monday, April 1, 2013, whether to deny a patent to Novartis AG for its cancer treatment in a landmark case that would allow Indian companies to continue producing cheaper versions of many lifesaving medicines. (AP Photo/Saurabh Das, File)

FILE - In this Dec. 21, 2012 file photo, an Indian activist from a health group holds a placard while participating in a protest against Swiss drugmaker Novartis AG outside their office in Mumbai, India. India's Supreme Court is to rule Monday, April 1, 2013, whether to deny a patent to Novartis AG for its cancer treatment in a landmark case that would allow Indian companies to continue producing cheaper versions of many lifesaving medicines. (AP Photo/Rajanish Kakade, File)

(AP) ? India's Supreme Court is to rule Monday on a landmark patent case involving Swiss drugmaker Novartis AG that focuses on demands by major companies that their investments be protected, against Indian companies that say they should be allowed to continue producing cheaper generic versions of many lifesaving medicines.

A decision in the seven-year legal battle is keenly awaited by the two most interested parties? big pharma companies and health aid groups ? with both sides saying the outcome will set a precedent with far-reaching consequences for the future availability of the drugs.

"Across the world, people rely on India for supplies of affordable versions of expensive patented medicines," said Leena Menghaney of Doctors Without Borders. "This case will have fundamental consequences."

The case goes back to 2006 when Novartis' application for a fresh patent in India for its cancer drug imatinib mesylate was rejected by the Indian patent office.

The patent authority cited a legal provision in India's 2005 patent law aimed at preventing companies from getting fresh patents for making only minor changes to existing medicines ? a practice known as "evergreening."

The drugmaker has argued that its leukemia drug Gleevec, known in Europe and India as Glivec, was a newer, more easily absorbed version that qualified for a fresh patent.

The company filed an appeal, but India's patent appeals office turned it down in 2009 on the grounds the company was unable to show significant increase in efficacy of the drug.

Novartis then approached the Supreme Court in August 2009, which heard arguments seeking to challenge the interpretation and application of India's patent law in the case.

Gleevec, used in treating chronic myeloid leukemia and some other cancers, costs a patient about $2,600 a month. Its generic version was available in India for around $175 per month.

"The difference in price was huge. The generic version makes it affordable to so many more poor people, not just in India, but across the world," said Y.K. Sapru, of the Mumbai-based Cancer Patients Aid Association.

The case once again pits big pharmaceutical companies against health activists and aid groups with both sections arguing that the judgment would be an important milestone for the future of the pharmaceutical industry worldwide.

"The Novartis verdict is important because it will determine whether India gets to limit patents to genuine new drugs, or whether drug companies get to "evergreen" their patents until eternity, simply by re-patenting a slightly modified version of a known substance," said Ellen 't Hoen, a pharmaceutical law and policy consultant.

Western pharmaceutical companies have warned that a rejection of Novartis' application would discourage investment in research and innovation, and would hobble drugmakers' efforts to refine and improve their products.

The international drug majors have been pushing for stronger patent protection in India to regulate the country's $26 billion generic drug industry, which they say often flouts intellectual property rights.

In a statement sent to The Associated Press late last year, Novartis said patent protection was important to ensure effective protection for innovation.

"Knowing we can rely on patents in India benefits government, industry and patients because research-based organizations will know if investing in the development of better medicines for India is a viable long-term option," the company said.

Groups such as Doctors Without Borders say cheaply made Indian generics are a lifesaver for millions of patients in poor countries who cannot afford to pay Western prices to treat diseases such as cancer, malaria and HIV.

India, which has emerged as the world's pharmacy for the poor, has come under intense scrutiny from pharmaceutical giants who say India's 2005 Patent Act fails to guarantee the rights of investors who finance drug research and development.

The country's recent decision to allow a local manufacturer to produce a generic version of Bayer's patented cancer drug Nexavar, to make the drug available to the public at a reasonably affordable price, has also not gone down well with Western pharmaceutical companies.

Health and aid groups were clearly nervous before the top court rules on the Novartis case.

"Generic companies depend on the freedom to operate. If there are too many intellectual property-related challenges, then the companies very quickly withdraw from making that drug," said Menghaney.

The groups fear that a ruling in favor of Novartis would lead to a proliferation of patents ? some based on a minor tweaking of formulation and dosages ?on dozens of other generic medicines that Indian companies have been producing and supplying to needy nations at far lower costs than those charged by Western drug manufacturers.

And the fallout of the judgment will be felt across the world, says Menghaney. "It's not just about India."

"If generic competition on many crucial medicines ends, then prices for these medicines will increase, both in India and across the developing world. This would be devastating for millions who rely on India for affordable medicines."

Associated Press

Source: http://hosted2.ap.org/APDEFAULT/cae69a7523db45408eeb2b3a98c0c9c5/Article_2013-03-31-India-Patent%20Battle/id-9299251350894549ac0c2d134052ebb5

iOS 6 Release Date Canelo Alvarez Chavez vs Martinez Yunel Escobar Irish Daily Star Black Mesa matt ryan

Keep Drinks Upright with a Roll of Tape

Keep Drinks Upright with a Roll of Tape If you find yourself in a situation where your drink might get bumped, sticking it inside a big roll of tape can keep it from spilling.

This trick could come in handy at a party where someone might knock it over, but it has its uses in everyday life as well. I might use this at my computer desk or when playing video games so my drink won't get upended by any wires, and it could also save you from a big headache at your workbench, where an erratic swing of a hammer could send it flying.

My Drink Anti-Tipping Device | Reddit

Photo by Ace Barajas

Source: http://feeds.gawker.com/~r/lifehacker/full/~3/W1uzodpvz3Y/use-a-roll-of-tape-to-keep-your-drink-upright

miguel Justin Timberlake Grammys frank ocean adam levine mumford and sons miranda lambert prince